AMS:REN 23 December 2025

RELX PLC Stock (LSE: REL, NYSE: RELX): Buyback Update, 2026 Results Date, and Fresh Analyst Forecasts (23 Dec 2025)

RELX PLC completed its 2025 share buyback, purchasing 39.5 million shares for £1.5 billion, and announced a new £250 million buyback to run from 2 January to 6 February 2026. The company cancelled 55 million treasury shares, leaving 1.82 billion shares outstanding. RELX shares last traded at 3,046p in London and $40–$41 on the NYSE ADR line.

23 December 2025

AMS:REN·Earnings Reports·LSE:REL·NYSE:RELX·Share Buybacks·Stock Market

Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).